Core Insights - As of December 10, 30 stocks reached their 52-week highs, with Design Metropolis (01545), Platinum Holdings (00459), and China Boton (03318) leading the increase rates at 40.82%, 35.48%, and 30.23% respectively [1][2] 52-Week Highs - Design Metropolis (01545) closed at 0.124, with a peak of 0.138, achieving a high rate of 40.82% [1] - Platinum Holdings (00459) closed at 0.121, with a peak of 0.126, achieving a high rate of 35.48% [1] - China Boton (03318) closed at 2.090, with a peak of 2.800, achieving a high rate of 30.23% [1] - Other notable stocks include: - China New Holdings (08125) at 25.00% [1] - Qiaoyang International Holdings (08070) at 14.46% [1] 52-Week Lows - The stock with the largest decline was Jingye Mingbang Group (02231), which fell to 0.099, a decrease of 26.40% [2] - Other significant declines included: - Zhonggang Petroleum (00632) at -16.40% [2] - Guofu Hydrogen Energy (02582) at -13.31% [2] - Additional stocks with notable declines: - Haotian International Construction Investment (01341) at -11.11% [2] - Jiaming Group Holdings (01271) at -10.00% [2]

Core Viewpoint - The actual controller of Rhein Biotech, Qin Benjun, is planning a change in the company's control, leading to a stock suspension and a potential acquisition of at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. [1][2][5] Group 1: Control Change - Qin Benjun is preparing to transfer part of his shares and relinquish voting rights, indicating a potential change in control of Rhein Biotech [2][5] - A "Control Change Intent Agreement" has been signed by relevant parties, but specific transaction details are still under negotiation [5] - The transaction may result in a change of the controlling shareholder and actual controller of the company [5] Group 2: Acquisition Details - Rhein Biotech plans to acquire at least 80% of Beijing Jinkangpu, which will become a subsidiary and included in the consolidated financial statements [5][9] - The acquisition aims to enhance Rhein Biotech's capabilities in food and health product development, leveraging synergies between the two companies [9] Group 3: Company Background - Rhein Biotech specializes in the research, production, and sales of natural health products and is a leading player in the global plant extraction industry [12] - As of the end of the third quarter, Qin Benjun holds 271.39 million shares, representing 36.59% of the company [10][11] - The company's stock price was reported at 8.7 yuan per share, with a total market value of 64.52 billion yuan as of December 9 [13]

Group 1 - The company, Rhine Biology, announced a suspension of trading on December 10, 2025, due to plans for a change in control and the issuance of shares to acquire assets [2][4] - The controlling shareholder, Qin Benjun, is planning to transfer part of his shares and relinquish voting rights, with a control change agreement already signed with key parties [4] - The company intends to acquire 80% of Beijing Jinkangpu's shares through share issuance and raise matching funds from Guangzhou Defu Nutrition [4][5] Group 2 - The transaction aims to integrate Beijing Jinkangpu into the listed company, enhancing synergy in the food and beverage and health product sectors, thereby improving R&D capabilities and market coverage [5] - Rhine Biology specializes in the production of natural health products, focusing on the R&D and production of plant functional ingredients, with over 300 standardized extraction technologies [5] - In the first three quarters of this year, the company reported revenue of 1.272 billion yuan, an increase of 8.73%, while net profit attributable to shareholders fell by 30.73% to 70.3953 million yuan [5]

本次交易完成后，北京金康普将成为公司的控股子公司，纳入合并财务报表范围。本次交易不构成重大 资产重组及重组上市。 本次交易将北京金康普纳入上市公司体系，双方将充分发挥业务上下游的协同效应。上市公司在食品饮 料、保健品领域的配方研发能力与核心竞争力将得到进一步提升，同时更精准地覆盖终端消费品牌，提 高业务附加值；北京金康普可依托上市公司获得天然原料供应保障和全球市场营销体系协同赋能，最终 实现双方优势资源互补、合作共赢的发展格局。 莱茵生物表示，公司控制权变更、发行股份及支付现金购买资产并募集配套资金事项目前处于筹划阶 段，尚存在重大不确定性，敬请广大投资者注意投资风险。 明起停牌。 莱茵生物（002166）12月9日晚间公告，公司于2025年12月8日收到控股股东、实际控制人秦本军的通 知，秦本军正在筹划公司控制权变更事宜。公司股票自2025年12月10日开市起停牌，预计停牌时间不超 过10个交易日。 公告显示，秦本军及公司已与本次交易的主要交易对方广州德福营养投资合伙企业（有限合伙）（简 称"广州德福营养"）、德福金康普控股有限合伙企业、厦门德福金普投资合伙企业（有限合伙）分别签 署了《控制权变更意向协议》 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年11月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 建業實業有限公司 | | | 呈交日期: | 2025年12月1日 | | | I. 法定/註冊股本變動 | 不適用 | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 第 3 頁 共 10 頁 v 1.1.1 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00216 | | 說明 | 建業實業 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 551,368,153 | | 0 | | 5 ...

截至2025年9月30日止过去6个月，本集团收入达4.47亿港元，较去年同期3.229亿港元增加约38.4%。更 重要的是，我们将去年同期的亏损120万港元扭转为核心溢利1530万港元。此强劲表现并非偶然，而是 源于纪律严明的执行力，以及广州住宅项目"港汇台"在重重挑战的物业市场中仍取得优异的销售业绩。 建业实业(00216)发布2025-26中期业绩，该集团取得收入4.47亿港元，同比增加38.43%;公司拥有人应占 亏损2.3亿港元，同比增加232%;每股亏损0.417港元。 ...

Core Viewpoint - Jianye Industrial (00216) reported a significant increase in revenue for the 2025-26 interim results, achieving HKD 447 million, a year-on-year increase of 38.43%, while the loss attributable to shareholders rose to HKD 230 million, an increase of 232% [1] Financial Performance - The group's revenue reached HKD 447 million for the six months ending September 30, 2025, compared to HKD 322.9 million in the same period last year, marking an approximate increase of 38.4% [1] - The company turned last year's loss of HKD 1.2 million into a core profit of HKD 15.3 million, indicating a strong performance driven by disciplined execution [1] Market Performance - The strong performance is attributed to the successful sales of the Guangzhou residential project "Ganghui Tai," which performed well despite challenges in the property market [1]

格隆汇11月25日丨建业实业(00216.HK)公告，截至2025年9月30日止过去6个月，集团收入达港币4.47亿 元，较去年同期增加约38.4%。更重要的是，公司将去年同期亏损港币120万元扭转为核心溢利港币 1530万元。此强劲表现并非偶然，而是源于纪律严明的执行力，以及广州住宅项目"港汇台"在重重挑战 的物业市场中仍取得优异的销售业绩。公司为团队的成就深感自豪。董事会不建议派发截至2025年9月 30日止6个月中期股息(2024年：无)。 但必须承认：公司同样面临市场逆风。投资物业重估亏损对资产负债表造成影响，金额约达港币2.45亿 元，较去年港币6810万元大幅攀升。因此，本期间股东应占亏损净额约为港币2.3亿元。这些是公司必 须迎头面对的严酷现实。 全球经济持续动荡。截至本主席报告，美国政府经历逾四10日停摆后重启运作，为全球市场带来不确定 因素。从中国到美国、到香港本地，失业水平攀升的迹象随处可见。通胀与利率仍居高不下，在至关重 要的圣诞节来临前夕，消费者信心持续低迷。中国房地产行业持续调整，政策支持虽已稳定市场但尚未 重启增长。香港物业市场深陷办公室与零售店铺空置率高企的困境，但公司看到酒店业 ...

Financial Performance - The company's revenue for the six months ended September 30, 2025, reached HKD 447 million, an increase of approximately 38.4% compared to HKD 322.9 million in the same period last year[3]. - The company achieved a core profit of HKD 15.3 million, reversing a loss of HKD 1.2 million from the previous year[3]. - The overall loss for the period was HKD 278.2 million, compared to a loss of HKD 49.1 million in the previous year[13]. - The net loss attributable to shareholders for the period was approximately HKD 230 million[3]. - The company experienced a loss before tax of HKD 274,145,000 for the six months ended September 30, 2025, compared to a profit of HKD 105,346,000 for the same period in the previous year[24][27]. - Basic loss per share for the period was HKD 0.417, compared to HKD 0.125 in 2024, reflecting a higher loss attributable to shareholders[39]. - The total tax expense for the period was HKD 4,044,000, significantly lower than HKD 19,105,000 in the previous year[38]. Revenue Breakdown - The company reported a total revenue of HKD 447,032,000 for the six months ended September 30, 2025, with property development contributing HKD 188,689,000 and property investment contributing HKD 238,079,000[24]. - Property sales revenue reached HKD 188,689,000 for the six months ended September 30, 2025, compared to HKD 52,643,000 in the previous year, marking a significant increase of 258%[32]. - Total rental income for the same period was HKD 232,282,000, slightly down from HKD 248,950,000 in 2024[33]. - The property management and parking management business generated revenue of HKD 20,300,000 during the review period, down from HKD 24,400,000 in 2024, with an operating loss of HKD 7,200,000[57]. Asset and Liability Overview - As of September 30, 2025, total non-current assets amounted to HKD 17,226,273,000, a decrease from HKD 17,392,723,000 as of March 31, 2025[16]. - Current assets totaled HKD 2,624,182,000, down from HKD 2,716,343,000 as of March 31, 2025, with cash and cash equivalents decreasing to HKD 903,089,000 from HKD 1,105,641,000[16]. - Total liabilities increased to HKD 9,153,754,000 as of September 30, 2025, compared to HKD 9,203,447,000 as of March 31, 2025[17]. - Non-current liabilities totaled HKD 7,619,940,000 as of September 30, 2025, down from HKD 7,849,254,000 as of March 31, 2025[17]. - The company's net asset value was HKD 10,696,701,000 as of September 30, 2025, slightly down from HKD 10,805,619,000 as of March 31, 2025[17]. - The debt ratio slightly increased to 61.8% as of September 30, 2025, compared to 59.8% as of March 31, 2025, remaining at an acceptable level[48]. Investment and Property Valuation - The company reported a significant increase in investment in joint ventures, with investments amounting to HKD 390,770,000 as of September 30, 2025[29]. - The company recorded a net revaluation loss of investment properties amounting to HKD 245,300,000, compared to HKD 68,100,000 in 2024, which is a non-cash loss[48]. - The fair value of the investment property portfolio as of September 30, 2025, is HKD 15,205,000,000, a decrease of HKD 245,300,000 from March 31, 2025, primarily due to revaluation losses in Hong Kong and mainland China properties[56]. - The investment property portfolio in mainland China includes eight major projects with a total floor area of approximately 494,000 square meters, achieving an average occupancy rate of 68% during the review period, projected to increase to 72% in 2024[53]. - The Hong Kong investment portfolio covers office buildings, hotels, and data centers with a total floor area of approximately 497,000 square feet, achieving an average occupancy rate of 98% during the review period, expected to decrease to 95% in 2024[54][55]. Operational Insights - The company is focusing on technology-driven investments and restructuring management to enhance partnerships in this area[7]. - The anticipated 50 basis point interest rate cut is expected to lower financing costs, but major business activities have not significantly reignited as expected[8]. - The company remains cautiously optimistic about new opportunities arising from the Asia-Pacific Economic Cooperation meeting in Shenzhen and the city's transformation into a technology hub[8]. - The group employed approximately 300 employees as of September 30, 2025, down from approximately 330 employees as of March 31, 2025[66]. - The group has maintained a prudent financing and financial policy, primarily managing its funding needs based on short to medium-term benchmarks[64]. Corporate Governance and Compliance - The audit committee has reviewed the group's financial reporting procedures and internal controls, with the interim results for the six months ended September 30, 2025, being unaudited but reviewed by the audit committee[71]. - The board believes that the continuity of the chairman and the managing director is crucial for consistent leadership and smooth operations, despite deviations from corporate governance codes[70].

格隆汇11月13日丨建业实业(00216.HK)公告，公司订于2025年11月25日(星期二)举行董事会会议，藉以 (当中包括)考虑及批准公司及其附属公司截至2025年9月30日止6个月中期业绩及考虑派发中期股息(如 有)。 ...